首页> 外文期刊>Clinical and experimental metastasis >Early tumor shrinkage as a potent predictor of outcome in KRAS wild-type colorectal liver-limited metastases treated with cetuximab plus chemotherapy: lessons from a randomized, controlled trial

【24h】

Early tumor shrinkage as a potent predictor of outcome in KRAS wild-type colorectal liver-limited metastases treated with cetuximab plus chemotherapy: lessons from a randomized, controlled trial

机译：早期肿瘤缩小是西妥昔单抗联合化疗治疗KRAS野生型结直肠肝有限转移的有效预后指标：一项来自随机对照试验的经验教训

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical and experimental metastasis》 |2015年第3期|共2页
作者
Ye Le-chi; Wei Ye; Ren Li; Zhu De-xiang; Chang Wen-ju; Xu Jian-min;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Early tumor shrinkage as a potent predictor of outcome in KRAS wild-type colorectal liver-limited metastases treated with cetuximab plus chemotherapy: lessons from a randomized, controlled trial [J] . Ye Le-chi, Wei Ye, Ren Li, Clinical and experimental metastasis . 2015,第3期

机译：早期肿瘤缩小是西妥昔单抗联合化疗治疗KRAS野生型结直肠肝有限转移的有效预后指标：一项来自随机对照试验的经验教训
2. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: An analysis of the AIO KRK-0104 trial [J] . VonEinemJ.C., HeinemannV., VonWeikersthalL.F., Journal of Cancer Research and Clinical Oncology . 2014,第9期

机译：西妥昔单抗联合化疗治疗KRAS密码子12/13野生型转移性结直肠癌患者的左侧原发性肿瘤预后良好：AIO KRK-0104试验分析
3. Impact of early tumor shrinkage on clinical outcome in wild- type- KRAS colorectal liver metastases treated with cetuximab [J] . Ye Le-chi, Wei Ye, Zhu De-xiang, Journal of gastroenterology and hepatology . 2015,第4期

机译：早期肿瘤缩小对西妥昔单抗治疗的野生型KRAS大肠肝转移临床疗效的影响
4. Resilience and metacognitions as predictors of outcome in a randomized controlled treatment trial of generalized anxiety disorder [C] . Hjemdal O., Hagen R., Ottesen Kennair Leif E., World Congress on Resilience. . 2014

机译：随机对照治疗试验的预测因子作为综合焦虑症的随机对照治疗试验的预测因素
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial [O] . J. C. von Einem, V. Heinemann, L. Fischer von Weikersthal, -1

机译：西妥昔单抗联合化疗治疗KRAS密码子12/13野生型转移性结直肠癌患者的左侧原发性肿瘤预后良好：AIO KRK-0104试验分析
7. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial [O] . J. C. von Einem, V. Heinemann, L. Fischer von Weikersthal, 2014

机译：西妥昔单抗联合化疗治疗KRAS密码子12/13野生型转移性结直肠癌患者的左侧原发性肿瘤预后良好：AIO KRK-0104试验分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号